Now that cancer is considered a disease of the genome, with at least hundreds of variations, access to information about common mutations and the efforts to fight them is considered critical for progress against the disease.
Read Full Article »
Now that cancer is considered a disease of the genome, with at least hundreds of variations, access to information about common mutations and the efforts to fight them is considered critical for progress against the disease.